Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
48.3M
-
Shares change
-
-853K
-
Total reported value, excl. options
-
$1.86B
-
Value change
-
-$48.6M
-
Put/Call ratio
-
3.49
-
Number of buys
-
135
-
Number of sells
-
-120
-
Price
-
$38.61
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q4 2022
310 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q4 2022.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.3M shares
.
Largest 10 shareholders include BlackRock Inc. (7.25M shares), VANGUARD GROUP INC (4.93M shares), MACQUARIE GROUP LTD (2.04M shares), ARMISTICE CAPITAL, LLC (1.89M shares), BAILLIE GIFFORD & CO (1.87M shares), STATE STREET CORP (1.62M shares), RENAISSANCE TECHNOLOGIES LLC (1.59M shares), LOOMIS SAYLES & CO L P (1.47M shares), Invesco Ltd. (1.36M shares), and Stephens Investment Management Group LLC (1.17M shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.